line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,-29663100.0,CHEMFAB.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.3,CHEMFAB.NS
Normalized EBITDA,2025-03-31 00:00:00,508386000.0,CHEMFAB.NS
Total Unusual Items,2025-03-31 00:00:00,-98877000.0,CHEMFAB.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,-98877000.0,CHEMFAB.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,-69403000.0,CHEMFAB.NS
Reconciled Depreciation,2025-03-31 00:00:00,363313000.0,CHEMFAB.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,2184549000.0,CHEMFAB.NS
EBITDA,2025-03-31 00:00:00,409509000.0,CHEMFAB.NS
EBIT,2025-03-31 00:00:00,46196000.0,CHEMFAB.NS
Net Interest Income,2025-03-31 00:00:00,-49250000.0,CHEMFAB.NS
Interest Expense,2025-03-31 00:00:00,49250000.0,CHEMFAB.NS
Interest Income,2025-03-31 00:00:00,,CHEMFAB.NS
Normalized Income,2025-03-31 00:00:00,-189100.0,CHEMFAB.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,-69403000.0,CHEMFAB.NS
Total Expenses,2025-03-31 00:00:00,3269849000.0,CHEMFAB.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,CHEMFAB.NS
Diluted Average Shares,2025-03-31 00:00:00,,CHEMFAB.NS
Basic Average Shares,2025-03-31 00:00:00,,CHEMFAB.NS
Diluted EPS,2025-03-31 00:00:00,,CHEMFAB.NS
Basic EPS,2025-03-31 00:00:00,,CHEMFAB.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,-69403000.0,CHEMFAB.NS
Net Income Common Stockholders,2025-03-31 00:00:00,-69403000.0,CHEMFAB.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,CHEMFAB.NS
Net Income,2025-03-31 00:00:00,-69403000.0,CHEMFAB.NS
Minority Interests,2025-03-31 00:00:00,0.0,CHEMFAB.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,-69403000.0,CHEMFAB.NS
Net Income Continuous Operations,2025-03-31 00:00:00,-69403000.0,CHEMFAB.NS
Tax Provision,2025-03-31 00:00:00,66349000.0,CHEMFAB.NS
Pretax Income,2025-03-31 00:00:00,-3054000.0,CHEMFAB.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,71179000.0,CHEMFAB.NS
Special Income Charges,2025-03-31 00:00:00,-98877000.0,CHEMFAB.NS
Other Special Charges,2025-03-31 00:00:00,,CHEMFAB.NS
Write Off,2025-03-31 00:00:00,,CHEMFAB.NS
Impairment Of Capital Assets,2025-03-31 00:00:00,98877000.0,CHEMFAB.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-49250000.0,CHEMFAB.NS
Total Other Finance Cost,2025-03-31 00:00:00,,CHEMFAB.NS
Interest Expense Non Operating,2025-03-31 00:00:00,49250000.0,CHEMFAB.NS
Interest Income Non Operating,2025-03-31 00:00:00,,CHEMFAB.NS
Operating Income,2025-03-31 00:00:00,73894000.0,CHEMFAB.NS
Operating Expense,2025-03-31 00:00:00,1085300000.0,CHEMFAB.NS
Other Operating Expenses,2025-03-31 00:00:00,466935000.0,CHEMFAB.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,363313000.0,CHEMFAB.NS
Amortization,2025-03-31 00:00:00,,CHEMFAB.NS
Depreciation Income Statement,2025-03-31 00:00:00,363313000.0,CHEMFAB.NS
Selling General And Administration,2025-03-31 00:00:00,,CHEMFAB.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,CHEMFAB.NS
General And Administrative Expense,2025-03-31 00:00:00,,CHEMFAB.NS
Rent And Landing Fees,2025-03-31 00:00:00,,CHEMFAB.NS
Gross Profit,2025-03-31 00:00:00,1159194000.0,CHEMFAB.NS
Cost Of Revenue,2025-03-31 00:00:00,2184549000.0,CHEMFAB.NS
Total Revenue,2025-03-31 00:00:00,3343743000.0,CHEMFAB.NS
Operating Revenue,2025-03-31 00:00:00,3343743000.0,CHEMFAB.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,CHEMFAB.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.327575,CHEMFAB.NS
Normalized EBITDA,2024-03-31 00:00:00,624395000.0,CHEMFAB.NS
Total Unusual Items,2024-03-31 00:00:00,0.0,CHEMFAB.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,0.0,CHEMFAB.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,263231000.0,CHEMFAB.NS
Reconciled Depreciation,2024-03-31 00:00:00,223508000.0,CHEMFAB.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,2103338000.0,CHEMFAB.NS
EBITDA,2024-03-31 00:00:00,624395000.0,CHEMFAB.NS
EBIT,2024-03-31 00:00:00,400887000.0,CHEMFAB.NS
Net Interest Income,2024-03-31 00:00:00,-9422000.0,CHEMFAB.NS
Interest Expense,2024-03-31 00:00:00,9422000.0,CHEMFAB.NS
Interest Income,2024-03-31 00:00:00,20722000.0,CHEMFAB.NS
Normalized Income,2024-03-31 00:00:00,263231000.0,CHEMFAB.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,263231000.0,CHEMFAB.NS
Total Expenses,2024-03-31 00:00:00,2957527000.0,CHEMFAB.NS
Rent Expense Supplemental,2024-03-31 00:00:00,1684000.0,CHEMFAB.NS
Diluted Average Shares,2024-03-31 00:00:00,14352835.0,CHEMFAB.NS
Basic Average Shares,2024-03-31 00:00:00,14205666.0,CHEMFAB.NS
Diluted EPS,2024-03-31 00:00:00,18.34,CHEMFAB.NS
Basic EPS,2024-03-31 00:00:00,18.53,CHEMFAB.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,263231000.0,CHEMFAB.NS
Net Income Common Stockholders,2024-03-31 00:00:00,263231000.0,CHEMFAB.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,CHEMFAB.NS
Net Income,2024-03-31 00:00:00,263231000.0,CHEMFAB.NS
Minority Interests,2024-03-31 00:00:00,0.0,CHEMFAB.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,263231000.0,CHEMFAB.NS
Net Income Continuous Operations,2024-03-31 00:00:00,263231000.0,CHEMFAB.NS
Tax Provision,2024-03-31 00:00:00,128234000.0,CHEMFAB.NS
Pretax Income,2024-03-31 00:00:00,391465000.0,CHEMFAB.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,85446000.0,CHEMFAB.NS
Special Income Charges,2024-03-31 00:00:00,0.0,CHEMFAB.NS
Other Special Charges,2024-03-31 00:00:00,-2655000.0,CHEMFAB.NS
Write Off,2024-03-31 00:00:00,72000.0,CHEMFAB.NS
Impairment Of Capital Assets,2024-03-31 00:00:00,0.0,CHEMFAB.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-9422000.0,CHEMFAB.NS
Total Other Finance Cost,2024-03-31 00:00:00,8135000.0,CHEMFAB.NS
Interest Expense Non Operating,2024-03-31 00:00:00,9422000.0,CHEMFAB.NS
Interest Income Non Operating,2024-03-31 00:00:00,20722000.0,CHEMFAB.NS
Operating Income,2024-03-31 00:00:00,315441000.0,CHEMFAB.NS
Operating Expense,2024-03-31 00:00:00,854189000.0,CHEMFAB.NS
Other Operating Expenses,2024-03-31 00:00:00,397052000.0,CHEMFAB.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,223508000.0,CHEMFAB.NS
Amortization,2024-03-31 00:00:00,294000.0,CHEMFAB.NS
Depreciation Income Statement,2024-03-31 00:00:00,223508000.0,CHEMFAB.NS
Selling General And Administration,2024-03-31 00:00:00,114266000.0,CHEMFAB.NS
Selling And Marketing Expense,2024-03-31 00:00:00,74488000.0,CHEMFAB.NS
General And Administrative Expense,2024-03-31 00:00:00,39778000.0,CHEMFAB.NS
Rent And Landing Fees,2024-03-31 00:00:00,1684000.0,CHEMFAB.NS
Gross Profit,2024-03-31 00:00:00,1169630000.0,CHEMFAB.NS
Cost Of Revenue,2024-03-31 00:00:00,2103338000.0,CHEMFAB.NS
Total Revenue,2024-03-31 00:00:00,3272968000.0,CHEMFAB.NS
Operating Revenue,2024-03-31 00:00:00,3272968000.0,CHEMFAB.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,-1367007.317869,CHEMFAB.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.277904,CHEMFAB.NS
Normalized EBITDA,2023-03-31 00:00:00,1131065000.0,CHEMFAB.NS
Total Unusual Items,2023-03-31 00:00:00,-4919000.0,CHEMFAB.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,-4919000.0,CHEMFAB.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,645833000.0,CHEMFAB.NS
Reconciled Depreciation,2023-03-31 00:00:00,229312000.0,CHEMFAB.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,1744087000.0,CHEMFAB.NS
EBITDA,2023-03-31 00:00:00,1126146000.0,CHEMFAB.NS
EBIT,2023-03-31 00:00:00,896834000.0,CHEMFAB.NS
Net Interest Income,2023-03-31 00:00:00,1049000.0,CHEMFAB.NS
Interest Expense,2023-03-31 00:00:00,2448000.0,CHEMFAB.NS
Interest Income,2023-03-31 00:00:00,6228000.0,CHEMFAB.NS
Normalized Income,2023-03-31 00:00:00,649384992.682131,CHEMFAB.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,645833000.0,CHEMFAB.NS
Total Expenses,2023-03-31 00:00:00,2431284000.0,CHEMFAB.NS
Rent Expense Supplemental,2023-03-31 00:00:00,462000.0,CHEMFAB.NS
Diluted Average Shares,2023-03-31 00:00:00,14305922.0,CHEMFAB.NS
Basic Average Shares,2023-03-31 00:00:00,14160974.0,CHEMFAB.NS
Diluted EPS,2023-03-31 00:00:00,45.14,CHEMFAB.NS
Basic EPS,2023-03-31 00:00:00,45.61,CHEMFAB.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,645833000.0,CHEMFAB.NS
Net Income Common Stockholders,2023-03-31 00:00:00,645833000.0,CHEMFAB.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,CHEMFAB.NS
Net Income,2023-03-31 00:00:00,645833000.0,CHEMFAB.NS
Minority Interests,2023-03-31 00:00:00,0.0,CHEMFAB.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,645833000.0,CHEMFAB.NS
Net Income Continuous Operations,2023-03-31 00:00:00,645833000.0,CHEMFAB.NS
Tax Provision,2023-03-31 00:00:00,248553000.0,CHEMFAB.NS
Pretax Income,2023-03-31 00:00:00,894386000.0,CHEMFAB.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,17635000.0,CHEMFAB.NS
Special Income Charges,2023-03-31 00:00:00,-34147000.0,CHEMFAB.NS
Other Special Charges,2023-03-31 00:00:00,31643000.0,CHEMFAB.NS
Write Off,2023-03-31 00:00:00,2504000.0,CHEMFAB.NS
Impairment Of Capital Assets,2023-03-31 00:00:00,,CHEMFAB.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,1049000.0,CHEMFAB.NS
Total Other Finance Cost,2023-03-31 00:00:00,2731000.0,CHEMFAB.NS
Interest Expense Non Operating,2023-03-31 00:00:00,2448000.0,CHEMFAB.NS
Interest Income Non Operating,2023-03-31 00:00:00,6228000.0,CHEMFAB.NS
Operating Income,2023-03-31 00:00:00,879942000.0,CHEMFAB.NS
Operating Expense,2023-03-31 00:00:00,687197000.0,CHEMFAB.NS
Other Operating Expenses,2023-03-31 00:00:00,126231000.0,CHEMFAB.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,229312000.0,CHEMFAB.NS
Amortization,2023-03-31 00:00:00,691000.0,CHEMFAB.NS
Depreciation Income Statement,2023-03-31 00:00:00,228621000.0,CHEMFAB.NS
Selling General And Administration,2023-03-31 00:00:00,79175000.0,CHEMFAB.NS
Selling And Marketing Expense,2023-03-31 00:00:00,43532000.0,CHEMFAB.NS
General And Administrative Expense,2023-03-31 00:00:00,35643000.0,CHEMFAB.NS
Rent And Landing Fees,2023-03-31 00:00:00,462000.0,CHEMFAB.NS
Gross Profit,2023-03-31 00:00:00,1567139000.0,CHEMFAB.NS
Cost Of Revenue,2023-03-31 00:00:00,1744087000.0,CHEMFAB.NS
Total Revenue,2023-03-31 00:00:00,3311226000.0,CHEMFAB.NS
Operating Revenue,2023-03-31 00:00:00,3311226000.0,CHEMFAB.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,-1288366.07684,CHEMFAB.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.264823,CHEMFAB.NS
Normalized EBITDA,2022-03-31 00:00:00,628227000.0,CHEMFAB.NS
Total Unusual Items,2022-03-31 00:00:00,-4865000.0,CHEMFAB.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,-4865000.0,CHEMFAB.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,287468000.0,CHEMFAB.NS
Reconciled Depreciation,2022-03-31 00:00:00,222213000.0,CHEMFAB.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,1740078000.0,CHEMFAB.NS
EBITDA,2022-03-31 00:00:00,623362000.0,CHEMFAB.NS
EBIT,2022-03-31 00:00:00,401149000.0,CHEMFAB.NS
Net Interest Income,2022-03-31 00:00:00,5982000.0,CHEMFAB.NS
Interest Expense,2022-03-31 00:00:00,10130000.0,CHEMFAB.NS
Interest Income,2022-03-31 00:00:00,17203000.0,CHEMFAB.NS
Normalized Income,2022-03-31 00:00:00,291044633.92316,CHEMFAB.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,287468000.0,CHEMFAB.NS
Total Expenses,2022-03-31 00:00:00,2354835000.0,CHEMFAB.NS
Rent Expense Supplemental,2022-03-31 00:00:00,330000.0,CHEMFAB.NS
Diluted Average Shares,2022-03-31 00:00:00,14230483.0,CHEMFAB.NS
Basic Average Shares,2022-03-31 00:00:00,14122397.0,CHEMFAB.NS
Diluted EPS,2022-03-31 00:00:00,20.2,CHEMFAB.NS
Basic EPS,2022-03-31 00:00:00,20.36,CHEMFAB.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,287468000.0,CHEMFAB.NS
Net Income Common Stockholders,2022-03-31 00:00:00,287468000.0,CHEMFAB.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,CHEMFAB.NS
Net Income,2022-03-31 00:00:00,287468000.0,CHEMFAB.NS
Minority Interests,2022-03-31 00:00:00,0.0,CHEMFAB.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,287468000.0,CHEMFAB.NS
Net Income Continuous Operations,2022-03-31 00:00:00,287468000.0,CHEMFAB.NS
Tax Provision,2022-03-31 00:00:00,103551000.0,CHEMFAB.NS
Pretax Income,2022-03-31 00:00:00,391019000.0,CHEMFAB.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,31524000.0,CHEMFAB.NS
Special Income Charges,2022-03-31 00:00:00,-11242000.0,CHEMFAB.NS
Other Special Charges,2022-03-31 00:00:00,-1820000.0,CHEMFAB.NS
Write Off,2022-03-31 00:00:00,13062000.0,CHEMFAB.NS
Impairment Of Capital Assets,2022-03-31 00:00:00,,CHEMFAB.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,5982000.0,CHEMFAB.NS
Total Other Finance Cost,2022-03-31 00:00:00,1091000.0,CHEMFAB.NS
Interest Expense Non Operating,2022-03-31 00:00:00,10130000.0,CHEMFAB.NS
Interest Income Non Operating,2022-03-31 00:00:00,17203000.0,CHEMFAB.NS
Operating Income,2022-03-31 00:00:00,357857000.0,CHEMFAB.NS
Operating Expense,2022-03-31 00:00:00,614757000.0,CHEMFAB.NS
Other Operating Expenses,2022-03-31 00:00:00,116300000.0,CHEMFAB.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,222213000.0,CHEMFAB.NS
Amortization,2022-03-31 00:00:00,735000.0,CHEMFAB.NS
Depreciation Income Statement,2022-03-31 00:00:00,222213000.0,CHEMFAB.NS
Selling General And Administration,2022-03-31 00:00:00,39180000.0,CHEMFAB.NS
Selling And Marketing Expense,2022-03-31 00:00:00,15137000.0,CHEMFAB.NS
General And Administrative Expense,2022-03-31 00:00:00,24043000.0,CHEMFAB.NS
Rent And Landing Fees,2022-03-31 00:00:00,330000.0,CHEMFAB.NS
Gross Profit,2022-03-31 00:00:00,972614000.0,CHEMFAB.NS
Cost Of Revenue,2022-03-31 00:00:00,1740078000.0,CHEMFAB.NS
Total Revenue,2022-03-31 00:00:00,2712692000.0,CHEMFAB.NS
Operating Revenue,2022-03-31 00:00:00,2712692000.0,CHEMFAB.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,CHEMFAB.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,CHEMFAB.NS
Normalized EBITDA,2021-03-31 00:00:00,,CHEMFAB.NS
Total Unusual Items,2021-03-31 00:00:00,,CHEMFAB.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,CHEMFAB.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,CHEMFAB.NS
Reconciled Depreciation,2021-03-31 00:00:00,,CHEMFAB.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,CHEMFAB.NS
EBITDA,2021-03-31 00:00:00,,CHEMFAB.NS
EBIT,2021-03-31 00:00:00,,CHEMFAB.NS
Net Interest Income,2021-03-31 00:00:00,,CHEMFAB.NS
Interest Expense,2021-03-31 00:00:00,,CHEMFAB.NS
Interest Income,2021-03-31 00:00:00,4262000.0,CHEMFAB.NS
Normalized Income,2021-03-31 00:00:00,,CHEMFAB.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,CHEMFAB.NS
Total Expenses,2021-03-31 00:00:00,,CHEMFAB.NS
Rent Expense Supplemental,2021-03-31 00:00:00,751000.0,CHEMFAB.NS
Diluted Average Shares,2021-03-31 00:00:00,14103783.0,CHEMFAB.NS
Basic Average Shares,2021-03-31 00:00:00,14007448.0,CHEMFAB.NS
Diluted EPS,2021-03-31 00:00:00,-5.81,CHEMFAB.NS
Basic EPS,2021-03-31 00:00:00,-5.81,CHEMFAB.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,CHEMFAB.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,CHEMFAB.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,CHEMFAB.NS
Net Income,2021-03-31 00:00:00,,CHEMFAB.NS
Minority Interests,2021-03-31 00:00:00,,CHEMFAB.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,CHEMFAB.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,CHEMFAB.NS
Tax Provision,2021-03-31 00:00:00,,CHEMFAB.NS
Pretax Income,2021-03-31 00:00:00,,CHEMFAB.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,CHEMFAB.NS
Special Income Charges,2021-03-31 00:00:00,,CHEMFAB.NS
Other Special Charges,2021-03-31 00:00:00,-90000.0,CHEMFAB.NS
Write Off,2021-03-31 00:00:00,220000.0,CHEMFAB.NS
Impairment Of Capital Assets,2021-03-31 00:00:00,0.0,CHEMFAB.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,CHEMFAB.NS
Total Other Finance Cost,2021-03-31 00:00:00,3181000.0,CHEMFAB.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,CHEMFAB.NS
Interest Income Non Operating,2021-03-31 00:00:00,4262000.0,CHEMFAB.NS
Operating Income,2021-03-31 00:00:00,,CHEMFAB.NS
Operating Expense,2021-03-31 00:00:00,,CHEMFAB.NS
Other Operating Expenses,2021-03-31 00:00:00,,CHEMFAB.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,CHEMFAB.NS
Amortization,2021-03-31 00:00:00,1323000.0,CHEMFAB.NS
Depreciation Income Statement,2021-03-31 00:00:00,,CHEMFAB.NS
Selling General And Administration,2021-03-31 00:00:00,50247000.0,CHEMFAB.NS
Selling And Marketing Expense,2021-03-31 00:00:00,25042000.0,CHEMFAB.NS
General And Administrative Expense,2021-03-31 00:00:00,25205000.0,CHEMFAB.NS
Rent And Landing Fees,2021-03-31 00:00:00,751000.0,CHEMFAB.NS
Gross Profit,2021-03-31 00:00:00,,CHEMFAB.NS
Cost Of Revenue,2021-03-31 00:00:00,,CHEMFAB.NS
Total Revenue,2021-03-31 00:00:00,,CHEMFAB.NS
Operating Revenue,2021-03-31 00:00:00,,CHEMFAB.NS
